Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 167
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT04280029 | SELUTION SLR™ 014 In-stent Restenosis | ||
| NCT03983980 | Tapinarof for the Treatment of Plaque Psoriasis in Adults (3002) | ||
| NCT04568031 | Study of AZD1222 for the Prevention of COVID-19 in Japan | ||
| NCT00660673 | Open Label Continuation Treatment Study With Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease | ||
| NCT05546905 | A Study in Patients With BRAF V600E-mutant Metastatic Non-small Cell Lung Cancer (OCTOPUS) | ||
| NCT04368065 | COVID-19 Active Research Experience (CARE) | ||
| NCT05414422 | A Randomized, Placebo-Controlled, Double-Blind Study to Assess Safety and Efficacy of PCN-101 in TRD | ||
| NCT03402841 | Multicentre Study of Olaparib Maintenance Monotherapy in Platinum Sensitive Relapsed Non gBRCAm Ovarian Cancer Patients | ||
| NCT03544281 | To Evaluate Safety, Tolerability, and Clinical Activity of the Antibody-drug Conjugate, GSK2857916 Administered in Combination With Lenalidomide Plus Dexamethasone (Arm A), or in Combination With Bortezomib Plus Dexamethasone (Arm B) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) | ||
| NCT06412250 | A Multicenter Observational Registry to Evaluate Safety and Performance of Vivo ISAR (SECURE Global Registry) | ||
| NCT05761444 | Effectiveness and Safety Study of Early add-on of Ezetimibe With Atorvastatin in Very High-risk Patients | ||
| NCT04516746 | Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults | ||
| NCT03976518 | Atezolizumab in Advanced Non-small Cell Lung Cancer With Rare Histologies (CHANCE Trial) | ||
| NCT04612725 | A Study to Investigate the Use of Benralizumab in Patients With Chronic Spontaneous Urticaria Who Are Symptomatic Despite the Use of Antihistamines (ARROYO) | ||
| NCT05874804 | Carry Life@ UF System Clinical Study | ||
| NCT05016024 | Administration of a Molecular Complex of Resins, Polysaccharides and Polyphenols in Irritable Bowel Syndrome. | ||
| NCT04907968 | Study of Upifitamab Rilsodotin in Combination With Carboplatin in Participants With High-grade Serous Ovarian Cancer | ||
| NCT03627715 | Safety and Effectiveness of Propagermanium in Diabetic Kidney Disease Participants Receiving Irbesartan | ||
| NCT05731908 | A Study to Test How BI 690517 is Taken up in the Body of People With and Without Liver Problems | ||
| NCT03583164 | Evaluate F901318 (Olorofim) Treatment of Invasive Fungal Infections in Participants Lacking Treatment Options | ||
| NCT03120949 | Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis | ||
| NCT07049653 | Anifrolumab Pregnancy Study | ||
| NCT03566082 | Post-Approval Study of the R3 Biolox Delta Ceramic Acetabular System - Europe | ||
| NCT03937479 | Study Investigating the Effect of 4 Doses of RPL554 Given in Addition to Tiotropium to Patients With COPD | ||
| NCT07405983 | TOUCH® CMC 1 New Enrollment US Study | ||
| NCT06799221 | Expanded Access Program for OOS Obe-cel | ||
| NCT05856266 | An 18-month Low-interventional Study to Assess Joint Health in Haemophilia A and B Patients on Prophylaxis With Efmoroctocog Alfa or Eftrenonacog Alfa | ||
| NCT03767075 | A Modular Multi-Basket Trial to Improve Personalized Medicine in Cancer Patients (Basket of Baskets) | ||
| NCT04072835 | Safety Study of Etripamil Nasal Spray for Patients With Paroxysmal Supraventricular Tachycardia. NODE-303 | ||
| NCT04053387 | Long Term Extension Study of Tapinarof for Plaque Psoriasis in Adults (3003) | ||
| NCT02734004 | A Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors. | ||
| NCT05859854 | Cenobamate in Adults With Focal-Onset Seizures | ||
| NCT05985083 | A Study Of IMM47 In Subjects With Advanced Solid Tumors | ||
| NCT05970263 | IKANOS: Breztri Maintenance Versus Any Non-Triple Inhaled Therapy After Hospitalization for a COPD Exacerbation in the US | ||
| NCT05508750 | Growth and Safety Clinical Trial on a New Infant Formula | ||
| NCT04719832 | Placebo-controlled Efficacy and Safety Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype | ||
| NCT02503033 | A Study of HMPL-523 in Relapsed or Refractory Hematologic Malignancies | ||
| NCT04744363 | Pharmacokinetics, Safety and Tolerability Study of AVT04 to EU Approved and US Licensed Stelara (Ustekinumab) | ||
| NCT07000110 | Anifrolumab Malignancy and Serious Infections Study | ||
| NCT05560646 | A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe Endometriosis-related Pain | ||
| NCT02846753 | Implantation of the Venus P-Valve™ in the Pulmonic Position in Patients With Native Outflow Tracts | ||
| NCT05925595 | Intra-articular Administration of Med Device Made of Biological Vegetal Matrix for the Treatment of Knee Osteoarthritis | ||
| NCT06712563 | Pooled Analysis of Single-arm Studies of Budesonide/Glycopyrronium/Formoterol (BGF) in Routine Care Setting | ||
| NCT03615924 | Effect of Ticagrelor vs. Placebo in the Reduction of Vaso-occlusive Crises in Pediatric Patients With Sickle Cell Disease | ||
| NCT05066698 | ST266 Eyedrops for the Treatment of Persistent Corneal Epithelial Defects | ||
| NCT05169307 | CPX-351 Real-World Effectiveness and Safety Study | ||
| NCT04134728 | Efficacy and Safety of GSK3196165 (Otilimab) Versus Placebo and Sarilumab in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological Disease-modifying Antirheumatic Drug (DMARDs) and/or Janus Kinase (JAK) Inhibitors | ||
| NCT03881488 | Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies | ||
| NCT04605094 | Efficacy and Safety Study of the Use of Benralizumab for Patients With Moderate to Severe Atopic Dermatitis | ||
| NCT07475468 | CP382 - Intermittent Catheter (IC) PRO Panel Plan |
